CNS Pharmaceuticals (CNSP) Receivables - Net (2021 - 2023)
CNS Pharmaceuticals' (CNSP) quarterly Receivables - Net came in at $197605.0 in Q4 2023, up 15077.04% YoY from N/an in Q4 2022, and little changed on a QoQ basis from $197605.0 in Q3 2023.
CNS Pharmaceuticals (CNSP) Receivables - Net (2021 - 2023) Analysis & Trends
CNS Pharmaceuticals (CNSP) has 3 years of Receivables - Net data on file, last reported at $197605.0 in Q4 2023.
- Quarterly Receivables - Net rose 15077.04% year-over-year to $197605.0 in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $197605.0 (up 15077.04% YoY) and the FY2023 annual result came in at $197605.0, up 15077.04% from the prior year.
- Receivables - Net was little changed at $197605.0 in Q4 2023, from $197605.0 in the prior quarter.
- In the past five years, Receivables - Net ranged from a high of $655000.0 in Q4 2021 to a low of $1302.0 in Q4 2022.
- A 3-year average of $249823.4 and a median of $197605.0 in 2023 frame the typical range for Receivables - Net.
- Annual changes were most pronounced in 2022 — Receivables - Net plunged 99.8% — and 2023, when it surged 15077.04%.
- Tracing CNSP's Receivables - Net over 3 years: stood at $655000.0 in 2021, then sank by 99.8% to $1302.0 in 2022, then surged by 15077.04% to $197605.0 in 2023.
- The last three Receivables - Net figures came in at $197605.0 (Q4 2023), $197605.0 (Q3 2023), and $197605.0 (Q2 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | CNS Pharmaceuticals | 2.65 Mn | -4.55 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 197,605.00 |
| Dec 31, 2023 | 197,605.00 |
| Sep 30, 2023 | 197,605.00 |
| Sep 30, 2023 | 197,605.00 |
| Jun 30, 2023 | 197,605.00 |
| Jun 30, 2023 | 197,605.00 |
| Dec 31, 2022 | 1,302.00 |
| Dec 31, 2022 | 1,302.00 |
| Dec 31, 2021 | 655,000.00 |
| Dec 31, 2021 | 655,000.00 |